vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 9.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-7.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
PBYI vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $140.7M |
| Net Profit | — | $-3.2M |
| Gross Margin | 69.3% | 41.9% |
| Operating Margin | 22.7% | -1.6% |
| Net Margin | — | -2.3% |
| Revenue YoY | 27.7% | 9.1% |
| Net Profit YoY | — | 62.1% |
| EPS (diluted) | $0.26 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $140.7M | ||
| Q3 25 | $54.5M | $118.8M | ||
| Q2 25 | $52.4M | $105.1M | ||
| Q1 25 | $46.0M | $104.2M | ||
| Q4 24 | $59.1M | $129.0M | ||
| Q3 24 | $80.5M | $118.6M | ||
| Q2 24 | $47.1M | $120.3M | ||
| Q1 24 | $43.8M | $120.0M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $8.8M | $-11.7M | ||
| Q2 25 | $5.9M | $-17.3M | ||
| Q1 25 | $3.0M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $20.3M | $-39.2M | ||
| Q2 24 | $-4.5M | $27.0K | ||
| Q1 24 | $-4.8M | $-50.2M |
| Q4 25 | 69.3% | 41.9% | ||
| Q3 25 | 77.7% | 42.8% | ||
| Q2 25 | 76.5% | 35.9% | ||
| Q1 25 | 77.1% | 39.4% | ||
| Q4 24 | 76.4% | 42.9% | ||
| Q3 24 | 63.9% | 29.7% | ||
| Q2 24 | 77.4% | 40.7% | ||
| Q1 24 | 75.5% | 34.8% |
| Q4 25 | 22.7% | -1.6% | ||
| Q3 25 | 17.6% | -10.2% | ||
| Q2 25 | 12.7% | -13.5% | ||
| Q1 25 | 8.7% | -13.9% | ||
| Q4 24 | 22.6% | -6.0% | ||
| Q3 24 | 27.4% | -39.5% | ||
| Q2 24 | -4.6% | -12.1% | ||
| Q1 24 | -5.3% | -19.3% |
| Q4 25 | — | -2.3% | ||
| Q3 25 | 16.2% | -9.9% | ||
| Q2 25 | 11.2% | -16.5% | ||
| Q1 25 | 6.5% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | 25.2% | -33.1% | ||
| Q2 24 | -9.6% | 0.0% | ||
| Q1 24 | -11.0% | -41.8% |
| Q4 25 | $0.26 | $0.03 | ||
| Q3 25 | $0.17 | $0.11 | ||
| Q2 25 | $0.12 | $0.16 | ||
| Q1 25 | $0.06 | $0.18 | ||
| Q4 24 | $0.40 | $0.08 | ||
| Q3 24 | $0.41 | $0.36 | ||
| Q2 24 | $-0.09 | $0.00 | ||
| Q1 24 | $-0.10 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $24.3M |
| Total DebtLower is stronger | $22.7M | $126.7M |
| Stockholders' EquityBook value | $130.3M | $-29.7M |
| Total Assets | $216.3M | $296.3M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $24.3M | ||
| Q3 25 | $94.4M | $32.4M | ||
| Q2 25 | $96.0M | $34.2M | ||
| Q1 25 | $93.2M | $21.6M | ||
| Q4 24 | $101.0M | $29.0M | ||
| Q3 24 | $96.7M | $23.4M | ||
| Q2 24 | $96.8M | $23.4M | ||
| Q1 24 | $107.2M | $34.5M |
| Q4 25 | $22.7M | $126.7M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | $70.7M | ||
| Q3 24 | $79.3M | $50.8M | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $-29.7M | ||
| Q3 25 | $115.3M | $-26.9M | ||
| Q2 25 | $104.7M | $-15.6M | ||
| Q1 25 | $97.1M | $1.3M | ||
| Q4 24 | $92.1M | $20.2M | ||
| Q3 24 | $71.1M | $28.0M | ||
| Q2 24 | $48.5M | $66.4M | ||
| Q1 24 | $51.0M | $65.5M |
| Q4 25 | $216.3M | $296.3M | ||
| Q3 25 | $202.9M | $302.1M | ||
| Q2 25 | $194.9M | $303.8M | ||
| Q1 25 | $196.2M | $293.8M | ||
| Q4 24 | $213.3M | $307.8M | ||
| Q3 24 | $220.7M | $309.3M | ||
| Q2 24 | $205.0M | $362.1M | ||
| Q1 24 | $214.1M | $382.1M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | 3.50× | ||
| Q3 24 | 1.12× | 1.82× | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $-5.8M |
| Free Cash FlowOCF − Capex | $14.4M | $-7.8M |
| FCF MarginFCF / Revenue | 19.1% | -5.5% |
| Capex IntensityCapex / Revenue | 0.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $-5.8M | ||
| Q3 25 | $9.7M | $-968.0K | ||
| Q2 25 | $14.1M | $-4.0M | ||
| Q1 25 | $3.6M | $-23.1M | ||
| Q4 24 | $15.6M | $6.8M | ||
| Q3 24 | $11.0M | $1.1M | ||
| Q2 24 | $1.0M | $-8.9M | ||
| Q1 24 | $11.2M | $-16.8M |
| Q4 25 | $14.4M | $-7.8M | ||
| Q3 25 | $9.7M | $-1.8M | ||
| Q2 25 | $14.1M | $-7.0M | ||
| Q1 25 | $3.6M | $-25.3M | ||
| Q4 24 | $15.6M | $5.7M | ||
| Q3 24 | $11.0M | $101.0K | ||
| Q2 24 | $1.0M | $-11.0M | ||
| Q1 24 | — | $-19.9M |
| Q4 25 | 19.1% | -5.5% | ||
| Q3 25 | 17.7% | -1.5% | ||
| Q2 25 | 26.8% | -6.6% | ||
| Q1 25 | 7.7% | -24.3% | ||
| Q4 24 | 26.4% | 4.4% | ||
| Q3 24 | 13.7% | 0.1% | ||
| Q2 24 | 2.1% | -9.2% | ||
| Q1 24 | — | -16.5% |
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.1% | 2.2% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 0.0% | 1.7% | ||
| Q1 24 | 0.0% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
